Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. META
5. IBM
6. PRIM
7. SPY
8. ACN
9. NVDA
10. BLZE

Go back to Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation
(NASDAQ: AMLX) Delayed: 16.54 +0.26 (1.60%)
Previous Close $16.28    52 Week High $ 
Open $16.06    52 Week Low $ 
Day High $17.17    P/E N/A 
Day Low $15.71    EPS $ 
Volume 1,111,156